References
- Flameng W, Herijgers P, Bogaerts K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation. 2003;107(12):1609–1613.
- Tanemoto K. Surgical indication and recent progress of mitral valve disease. Clinic All-Round. 2011;60:262–268. Japanese.
- Guidelines for Surgical and Interventional Treatment of Valvular Haert Disease (JCS 2012) [Internet]. Tokyo (Japan): The Japanese Association for Thoracic Surgery, the Japanese Society for Cardiovascular Surgery, Japanese College of Cardiology; 2012 [cited 2018 Aug 23]. Available from: http://www.j-circ.or.jp/guideline/pdf/JCS2012_ookita_h.pdf
- Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009;54(8):686–694.
- Shiroiwa T, Fukuda T, Ikeda S, et al. Development of an official guideline for the economic evaluation of drugs/medical devices in Japan. Value in Health: J Int Soc Pharmacoecon Outc Res. 2017;20(3):372–378.
- Central Social Insurance Medical Council [Internet]. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2017 [cited 2017 Dec 18]. Available from: http://www.mhlw.go.jp/stf/shingi/shingi-chuo.html?tid=128157
- Research team (Team Leader: Takashi Fukuda) on cost-effectiveness evaluation supported by Health and Labour Science Research Grants (Strategic Integrated Scientific Research Project). Guideline for Preparing Cost-Effectiveness Evaluation to the Central Social Insurance Medical Council version 2.0. [Internet]. Tokyo (Japan): Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health; 2019 [cited 2019 Aug 16]. Available from: https://c2h.niph.go.jp/tools/guideline/guideline_en.pdf
- Cameron HL, Bernard LM, Garmo VS, et al. A Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation. J Med Econ. 2014;17(8):599–615.
- Giannini C, Fiorelli F, De Carlo M, et al. Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation. Am J Cardiol. 2016;117(2):271–277.
- Velazquez EJ, Samad Z, Al-Khalidi HR, et al. The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J. 2015;170(5):1050.e3–1059.e3.
- Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol. 2012;59(2):130–139.
- Glower DD, Kar S, Trento A, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol. 2014;64(2):172–181.
- Abbott Vascular Co., Ltd. MitraClip STED 8.1.7 Clinical Results of AVJ-514 trial. Tokyo: Abbott Vascular Co., Ltd. (Japan); 2016.
- DPC tensuu hayami hyou 2017-nen 4-gatsu ban [DPC point table (April 2017 edition)]. Tokyo: Igakutsushinsha Co.; 2017. Japanese.
- The 4th medical fee survey specialized organization DPC evaluation subcommittee in FY2008 [Internet]. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2017 [cited 2017 Jun 28]. Available from: http://www.mhlw.go.jp/stf/shingi2/0000150723.html
- Insurance Reimbursement for Medical Devices (to be listed in April 2018) [Internet]. Tokyo (Japan): Central Social Insurance Medical Council; 2018 [cited 2019 Aug 16]. Available from: https://www.mhlw.go.jp/file/05-Shingikai-12404000-Hokenkyoku-Iryouka/0000192797.pdf
- Shinryou tensuu hayami hyou 2017-nen 4-gatsu ban [Medical treatment fee point April 2017]. Tokyo: Igakutsushinsha Co,; 2017. Japanese.
- Nihon iyakuhin shuu DB 2017-nen 4-gatsu ban [Japanese Drugs DB April 2017]. Tokyo: Jiho, Inc.; 2017. Japanese.
- Gohler A, Geisler BP, Manne JM, et al. Utility estimates for decision-analytic modeling in chronic heart failure–health states based on New York Heart Association classes and number of rehospitalizations. Value in Health: J Int Soc Pharmacoecon Outc Res. 2009;12:185–187.
- Chaplin S, Scuffham PA, Alon M, et al. Secondary prevention after PCI: the cost-effectiveness of statin therapy in the Netherlands. Netherlands Heart J. 2004;12:331–336.
- Marwick TH, Scuffham PA, Hunink MG. Selection for early surgery in asymptomatic mitral regurgitation: a Markov model. Int J Cardiol. 2013;165(2):266–272.
- Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26(4):410–420.
- Price Adjustment in the Pilot Introduction [Internet]. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2017 [cited 2017 Dec 18]. Available from: http://www.mhlw.go.jp/file/05-Shingikai-12404000-Hokenkyoku-Iryouka/0000182066.pdf
- Demographics [Internet]. Tokyo (Japan): National Institute of Population and Social Security Research; 2018 [cited 2018 Sep 25]. Available from: http://www.ipss.go.jp/syoushika/tohkei/Popular/Popular2016.asp?chap=2&title1=%87U%81D%94N%97%EE%95%CA%90l%8C%FB
- MITRACLIP [Internet]. Saint-Denis (France): Haute Autorité de Santé; 2017 [cited Dec 2017 18]. Available from: https://www.has-sante.fr/portail/jcms/c_2028916/fr/mitraclip
- Mitral Valve Clip for Treatment of Mitral Regurgitation [Internet]. Ontario (Canada): Health Quality Ontario; 2017 [cited 2017 Dec 18]. Available from: http://www.hqontario.ca/Evidence-to-Improve-Care/Health-Technology-Assessment/Reviews-And-Recommendations/Mitral-Valve-Clip-for-Treatment-of-Mitral-Regurgitation
- Medical Services Advisory Committee [Internet]. Canberra (Australia): MSAC. 1192.2 – The reduction of mitral regurgitation through tissue approximation using transvenous/transeptal techniques (resubmission); 2017 [cited 2017 Dec 18]. Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1192.2-public
- Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379(24):2307–2318.
- Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379(24):2297–2306.
- Eleid MF, Reeder GS, Malouf JF, et al. The learning curve for transcatheter mitral valve repair with MitraClip. J Interv Cardiol. 2016;29(5):539–545.
- Schillinger W, Athanasiou T, Weicken N, et al. Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip and lessons learned after the first 75 consecutive patients. Eur J Heart Fail. 2011;13(12):1331–1339.
- Nishimura RA, Bonow RO. Percutaneous repair of secondary mitral regurgitation – a tale of two trials. N Engl J Med. 2018;379(24):2374–2376.